Zhittya Genesis Medicine Inc.
Dr. Jack Jacobs is president of Zhittya Genesis, a biopharmaceutical company developing a biological drug which triggers angiogenesis and neurogenesis. He leads the company's efforts to obtain FDA approval for its drug to treat Parkinson's Disease, ALS, Alzheimer's, multiple sclerosis, and enhance stroke recovery.
Frontiers of Regenerative Medicine: Therapeutic Angiogenesis to Reverse Heart Disease, Parkinson's, and More
August 15, 2019, 10:00 am - 11:15 am PDT
Disease Reversal with Pharmaceutical Angiogenesis: New Therapies for Stroke, Parkinson's Disease and More
August 17, 2019, 11:45 am - 12:30 pm PDT